Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Our Entrepreneurs

We are proud to have been the capital partner to some of the most talented medtech teams in our industry. Our entrepreneurs have pioneered new treatments for chronic diseases, built entirely new commercial markets from the ground up, and ushered in the future of personalized medicine and connected care.

Acquired by Stryker

Acquired by Boston Scientific

Acquired by Edwards Lifesciences

Acquired by Wright Medical

Acquired by Alcon

Acquired by Covidien

IPO (NASDAQ: CVRX)

Acquired by Medtronic

IPO (NASDAQ: NARI)

Acquired by Philips

Acquired by CR Bard

Acquired by Johnson & Johnson

Acquired by Labcorp

Acquired by Boston Scientific

IPO (NYSE American: SENS)

Acquired by Terumo

IPO (NASDAQ: SGP)

Acquired by Abbott

Acquired by Merz

Acquired by Olympus

Acquired by Boston Scientific

Acquired by Philips

22

Novel FDA PMA & de novo 510k approvals

61

U.S. Commercial Product Launches

40

Level I Clinical Trials

34

Strategic Financings

31

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS®

Ready to change healthcare together? Contact us to arrange for investments in development and commercial stage companies.

Get in Touch

Our Latest

See All News
SpyGlass Pharma Announces Pricing of Initial Public Offering
Ventaris Surgical, Inc. Announces $30M Series A to Advance a Next-Generation System for Complete Kidney Stone Treatment
Apella Raises $80 Million to Transform the Hospital with Ambient AI and Computer Vision
Resources
News Vensana Innovation LP Access
Contact
[email protected] 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 7900 Tysons One Place Suite 320 McLean, VA 22102

© 2026 Vensana Capital Management, LLC | Privacy | Terms & Conditions